Xortx Therapeutics Stock Probability of Future Stock Price Finishing Under 1.27
| XRTX Stock | USD 1.15 0.04 3.36% |
XORTX |
XORTX Therapeutics Target Price Odds to finish below 1.27
The tendency of XORTX Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay under $ 1.27 after 90 days |
| 1.15 | 90 days | 1.27 | about 17.99 |
Based on a normal probability distribution, the odds of XORTX Therapeutics to stay under $ 1.27 after 90 days from now is about 17.99 (This XORTX Therapeutics probability density function shows the probability of XORTX Stock to fall within a particular range of prices over 90 days) . Probability of XORTX Therapeutics price to stay between its current price of $ 1.15 and $ 1.27 at the end of the 90-day period is about 10.49 .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.37 . This entails as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, XORTX Therapeutics will likely underperform. Additionally XORTX Therapeutics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. XORTX Therapeutics Price Density |
| Price |
Predictive Modules for XORTX Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as XORTX Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of XORTX Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
XORTX Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. XORTX Therapeutics is not an exception. The market had few large corrections towards the XORTX Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold XORTX Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of XORTX Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.46 | |
β | Beta against Dow Jones | 1.37 | |
σ | Overall volatility | 0.23 | |
Ir | Information ratio | -0.07 |
XORTX Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of XORTX Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for XORTX Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| XORTX Therapeutics generated a negative expected return over the last 90 days | |
| XORTX Therapeutics has high historical volatility and very poor performance | |
| XORTX Therapeutics may become a speculative penny stock | |
| Net Loss for the year was (2.16 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| XORTX Therapeutics currently holds about 13.42 M in cash with (6.58 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.03. | |
| XORTX Therapeutics has a frail financial position based on the latest SEC disclosures | |
| Latest headline from gurufocus.com: XORTX Announces Presentation at the Rare and Genetic Disease Summit |
XORTX Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of XORTX Stock often depends not only on the future outlook of the current and potential XORTX Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. XORTX Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 2 M | |
| Cash And Short Term Investments | 3.4 M |
XORTX Therapeutics Technical Analysis
XORTX Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. XORTX Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of XORTX Therapeutics. In general, you should focus on analyzing XORTX Stock price patterns and their correlations with different microeconomic environments and drivers.
XORTX Therapeutics Predictive Forecast Models
XORTX Therapeutics' time-series forecasting models is one of many XORTX Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary XORTX Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about XORTX Therapeutics
Checking the ongoing alerts about XORTX Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for XORTX Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| XORTX Therapeutics generated a negative expected return over the last 90 days | |
| XORTX Therapeutics has high historical volatility and very poor performance | |
| XORTX Therapeutics may become a speculative penny stock | |
| Net Loss for the year was (2.16 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| XORTX Therapeutics currently holds about 13.42 M in cash with (6.58 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.03. | |
| XORTX Therapeutics has a frail financial position based on the latest SEC disclosures | |
| Latest headline from gurufocus.com: XORTX Announces Presentation at the Rare and Genetic Disease Summit |
Additional Tools for XORTX Stock Analysis
When running XORTX Therapeutics' price analysis, check to measure XORTX Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XORTX Therapeutics is operating at the current time. Most of XORTX Therapeutics' value examination focuses on studying past and present price action to predict the probability of XORTX Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XORTX Therapeutics' price. Additionally, you may evaluate how the addition of XORTX Therapeutics to your portfolios can decrease your overall portfolio volatility.